Population-based Incidence of Myopericarditis after COVID-19 Vaccination in Danish Adolescents

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Ulrikka Nygaard, Københavns Universitet
  • ,
  • Mette Holm
  • Cathrine Bohnstedt, Københavns Universitet
  • ,
  • Qing Chai, Hjoerring Hospital
  • ,
  • Lisbeth Samsø Schmidt, Københavns Universitet
  • ,
  • Jens Jakob Herrche Petersen, Region Syddanmark
  • ,
  • Jesper Thaarup, Aalborg Universitet
  • ,
  • Ulla Birgitte Hartling, Syddansk Universitet
  • ,
  • Jesper Bjerre
  • Niels Grove Vejlstrup, Københavns Universitet
  • ,
  • Klaus Juul, Københavns Universitet
  • ,
  • Lone Graff Stensballe, Københavns Universitet

In this prospective nationwide multicenter study from Denmark, myopericarditis after Pfizer-BioNTech mRNA COVID-19 vaccination was identified in 13 males and 2 females between May 15 and September 15, 2021, among 133,477 vaccinated males and 127,857 vaccinated females 12-17 years of age, equaling 97 males and 16 females per million. In conclusion, the incidence of myopericarditis after COVID-19 vaccination among males appears higher than reports from the United States.

OriginalsprogEngelsk
TidsskriftPediatric Infectious Disease Journal
Vol/bind41
Nummer1
Sider (fra-til)E25-E28
Antal sider4
ISSN0891-3668
DOI
StatusUdgivet - jan. 2022

Se relationer på Aarhus Universitet Citationsformater

ID: 269840684